Digital Health Startups

Mosh is an online men's health clinic offering treatment and consultations remotely, aiming to make care more affordable and accessible. It serves men in Australia through a telehealth model.

1 investor

3D Kinetics offers a smartphone-based movement analysis application that uses AI and kinesiological algorithms to assess physical performance, detect imbalances, and predict or prevent injuries. It serves individuals, personal trainers, and fitness studio owners who want to track physical condition and adapt training.

1 investor

Motion is a musculoskeletal care provider founded by an orthopedist to offer patients with musculoskeletal pain non-surgical alternatives and patient-centered, evidence-based treatment rather than defaulting to surgery. It serves patients seeking care for orthopedic and musculoskeletal conditions.

1 investor

Motus Nova develops robotic exoskeletons that provide active-assisted neuro-rehabilitation in home settings for patients recovering from stroke and brain injuries. The company offers clinic-quality physical therapy at home through FDA-cleared robots guided by movement therapy principles, targeting patients with limited access to traditional in-clinic rehabilitation.

1 investor

Move This World provides video-based social-emotional learning and mental health curricula for PreK-12 schools and districts, spanning Tier 1-3 instruction, teletherapy, adult/educator wellness, and family engagement. Integrated with DESSA screening and assessment, it helps districts align instruction and interventions to identified student behavioral and mental health needs.

1 investor

Movido Health is a risk-bearing specialty management company offering a value-based care platform that combines claims-based patient identification, AI-driven engagement, and dedicated health coaches and clinical teams to manage chronic conditions and recovery across areas like oncology, cardiovascular, musculoskeletal, metabolic, and women's health. It serves patients, primary care providers and ACOs, and payers within value-based care and population health arrangements.

1 investor

mPATH Health develops an SMS-based behavioral science platform that guides patients through cancer screening decisions and increases completion rates across lung, breast, and colorectal screening programs. The platform serves health systems and Federally Qualified Health Centers (FQHCs) to automate patient navigation at scale.

1 investor

m-Path develops mobile assessment solutions that enable researchers and clinicians to transform research concepts into actionable insights. The company is a KU Leuven spin-off specializing in tools for the research and clinical trial sectors.

1 investor

MSICS Pharma develops naturally-sourced psilocybin products for pharmaceutical use, operating a GMP production facility that produces its flagship product MSX-06. The product is undergoing clinical trials with hospitals to treat mental health conditions including depression, OCD, anxiety, PTSD, and eating disorders.

1 investor

Luciana Lasus offers individual nutrition consultations, a nutrigenetic DNA test, and group programs focused on hormonal health, nutrition, and wellbeing for women over 40. She also runs an interdisciplinary women's health forum and provides talks and advisory services to organizations in Uruguay and Latin America.

1 investor

MultiplAI Health is developing an RNA-sequencing and AI-based whole blood screening test to detect complex diseases, with a focus on cardiovascular disorders and cancer. The technology analyzes molecular RNA variances in blood to identify increased risk of cardiovascular events, aiming to enable routine remote screening.

1 investor

MultiplexDX develops a molecular diagnostics platform for cancer detection using proprietary technologies that combine histopathology, biomarker quantification, and gene expression analysis. The company serves research institutions and clinical laboratories internationally, with a focus on improving diagnostic accuracy in oncology.

1 investor

The page discusses Age Related Macular Degeneration (AMD), a major cause of sight loss in people over 50 in the developed world, covering its types, symptoms, and public health impact rather than describing a company's products or services.

1 investor

Murj provides a software platform for cardiac clinics, tailoring its solution to each clinic's specific workflows and challenges. It operates in the healthcare technology space, focused on patient care management.

1 investor

Muse Capital is an early-stage venture capital firm that invests in consumer technology companies focused on how people care, play, and live. It provides capital, strategy, and hands-on support to founders in overlooked consumer markets.

1 investor

Muse develops eTAAL, a USB-C digital stethoscope, and eMurmur auscultation software that lets users record, filter, store in the cloud, and live-stream heart and lung sounds for telemedicine and remote patient monitoring. The system works across Android, iOS, and web browsers and offers an SDK for integration, targeting telehealth and in-person clinical use.

1 investor

Mútua Portuguesa de Saúde (MPS) is a mutual insurance cooperative offering health insurance to workers in the public, private, and social sectors in Portugal, with premiums proportional to income and no age limits, waiting periods, or pre-existing condition exclusions. Employers enroll their staff, who access care through the Future Healthcare medical network or free-choice reimbursement, managed via the MyMPS digital platform.

1 investor

AutoScribe is an AI-powered digital assistant developed by Mutuo Health Solutions that automates clinical documentation to reduce administrative burden on healthcare providers. The company, based in Toronto, serves physicians and healthcare practitioners in Canada.

1 investor

MVM is a healthcare-focused investment firm that provides growth equity to companies in medical technology, pharmaceuticals, diagnostics, digital health, life science tools, and contract research and manufacturing. Operating from Boston and London since 1997, it partners with management teams to scale differentiated healthcare products across global markets.

1 investor

MVSystem develops software solutions for healthcare facilities, including documentation, telemedicine, remote equipment management, and patient monitoring systems. The company serves clinics and hospitals primarily in Russia.

1 investor

MVT Pharma develops ultrasound contrast agents and theranostics to advance imaging and treatment capabilities. The company focuses on drug discovery and development in medical imaging and oncology.

1 investor

MX Labs develops an AI-powered health monitoring platform that measures 30+ vital signs through facial recognition technology using any standard camera, targeting healthcare providers and insurance companies. The system performs real-time analysis on the user's device without requiring external hardware or cloud processing.

1 investor

My 1Health is a medical travel platform that connects patients with accredited hospitals and specialists abroad, managing the full treatment journey from initial inquiry and hospital selection to travel coordination and follow-up care. Originating in Africa and now global, it serves patients, referring partners, insurers/TPAs, and hospitals across 190+ countries.

1 investor

My Emergency Doctor operates a telehealth service connecting Australian healthcare institutions with senior emergency physicians, providing remote specialist emergency care regardless of location or time of day.

1 investor